Pevion’s therapeutic Candida vaccine generates functional B cell memory in all vaccinees
Pevion Biotech AG announced further data from the ongoing clinical study of its therapeutic Candida vaccine PEV7, demonstrating the generation of specific and functional B cell memory in 100% of vaccinees. Furthermore, the results again confirm the capability of Pevion’s second generation v ... more
Pevion’s therapeutic Candida vaccine shows robust systemic and mucosal immunogenicity
Pevion Biotech AG announced latest results from the ongoing clinical study of its therapeutic Candida vaccine PEV7, showing high levels of specific antibodies and a 100% mucosal immune response rate. The announcement further included the results of the largest, international representative ... more
Pevion appoints Didier Hoch as Chairman of the Board
Pevion Biotech Ltd. announced the appointment of Didier Hoch as Chairman of its Board of Directors. Until recently, Dr Hoch was President of Sanofi-Pasteur MSD, where he played a pivotal role in launching innovative vaccines, such as Gardasil®, in Europe.
Prior to his position as President ... more